CYP1B1 and breast carcinoma: Among the seven studies in Caucasians, three reported no association between the CYP1B1 Val432Leu polymorphism and breast cancer risk [4,10,14], while three reported a risk effect for the valine allele [9,11,13]; one study reported an inverse association between the valine allele and breast cancer [12].